Vemurafenib Sensitizes Melanoma Cells to Temozolomide by Downregulating MGMT Expression.

Bingjie Ren(Soochow University), Rongrui Liang(Beckman Research Institute)
Research Square (Research Square)
October 1, 2020
10.21203/rs.3.rs-83301/v1
Cited by 0

Related Papers

Blocking MAPK/ERK pathway sensitizes hepatocellular carcinoma cells to temozolomide via downregulating MGMT expression
|Annals of Translational Medicine|2020|22